Phase IIb, Randomised, Double-blind, Placebo-controlled, Multi-centre Trial of Infliximab With Transcriptomic Biomarker and Mechanism Evaluation in Patients With Acute Pancreatitis
Phase of Trial: Phase II
Latest Information Update: 22 Jul 2019
Price : $35 *
At a glance
- Drugs Infliximab (Primary)
- Indications Pancreatitis
- Focus Therapeutic Use
- Acronyms RAPID-I
- 16 Jan 2019 Planned initiation date changed from 1 Nov 2018 to 1 Feb 2019.
- 01 Oct 2018 New trial record
- 16 Aug 2018 Planned End Date changed from 1 Apr 2021 to 30 Apr 2021.